The early phase after the diagnosis of Type 2 diabetes offers a chance to shape the individual's future outcome. The beneficial effects of dietary restriction with a very-low-calorie diet on Type 2 diabetes have gained prominence with the potential for 'remission' of Type 2 diabetes, particularly evident in those with diabetes of <4 years' duration [8] . Insulin therapy, as currently used, is often restricted to late in the course of Type 2 diabetes; however, shortterm intensive insulin therapy for 2-3 weeks with either continuous subcutaneous insulin infusion or multiple daily insulin injections in newly diagnosed Type 2 diabetes can normalize hyperglycaemia and induce long-term glycaemic control [9] . Predictors of remission, for both these strategies, include individuals with shorter duration of diabetes and fewer chronic Type 2 diabetes complications, which may reflect a greater reversible component of b-cell dysfunction [8, 9] . The key determinant of the likelihood of inducing sustained remission is early intervention.
Early in the course of Type 2 diabetes there may be sufficient reversibility in the disease process to stabilize progressive b-cell deterioration, with the potential to induce sustained drug-free remission in carefully chosen individuals. We believe that a multidisciplinary team composed of individuals with specialist skills (such as general practitioners with a special interest, diabetologists, pharmacists and diabetes specialist nurses) should be involved at the outset of care with a remit to sub-classify the disease process and determine the intensity and type of therapy at the outset. This would be a short, intensive partnership with primary care to produce a 'legacy effect', not a proposal to divert management away from primary care.
This approach would not be easy. The numbers of people diagnosed with Type 2 diabetes creates a major strain on resources and there are logistical issues which are potential barriers to adopting the new treatment paradigm. Education and resources are scarce; however, this must be offset against the resources required to deal with the vascular complications of untreated diabetes.
Perhaps, in the future, we will come to see the diagnosis of Type 2 diabetes as the time for multidisciplinary team input?
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